|
SYPL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.02002908528721E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.186400E-01 |
| Stage1-vs-Stage3 |
1.900990E-01 |
| Stage1-vs-Stage4 |
2.797600E-04 |
| Stage2-vs-Stage3 |
7.684300E-02 |
| Stage2-vs-Stage4 |
5.962200E-04 |
| Stage3-vs-Stage4 |
4.073800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.80989709067603E-11 |
| Normal-vs-Asian |
2.44249065417534E-15 |
| Caucasian-vs-AfricanAmerican |
9.168800E-01 |
| Caucasian-vs-Asian |
7.270600E-01 |
| AfricanAmerican-vs-Asian |
7.162200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.769800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.79959999999846E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.116600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.056600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.293200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.564600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.213600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.902600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.743600E-03 |
| Classical-VS-Follicular |
9.865900E-02 |
| Classical-VS-Other |
6.538400E-01 |
| Classical-VS-Normal |
1.62592161956354E-12 |
| Tall-VS-Follicular |
8.178600E-04 |
| Tall-VS-Other |
6.580400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.764800E-01 |
| Follicular-VS-Normal |
1.81754611361384E-12 |
| Other-VS-Normal |
8.37439999999967E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
6.658700E-03 |
|
|
